The Writers Guild of America went on strike three years ago in large part out of fears of writers being replaced by artificial intelligence. That has not happened — whether due to copyright issues, or ...

LONDON, March 5 (Reuters) - China is in talks with Iran to allow crude oil and Qatari liquefied natural gas vessels safe passage through the Strait of Hormuz as the U.S.-Israeli war on Tehran ...

“[AI] is making certain types of attacks more accessible to less sophisticated actors who can now leverage AI to enhance their capabilities and operate at greater scale,” said Amazon’s CSO Stephen ...

A financially motivated threat actor with little technical knowhow used generative AI (GenAI) to breach hundreds of FortiGate instances at scale. While this showcases how AI can scale workflows to ...

The report warns CSOs that while AI is helping unsophisticated threat actors, failure to implement cybersecurity basics is fatal regardless of the attacker's skill. A Russian-speaking threat actor is ...

A low-skilled cyber threat actor has been observed leveraging several generative AI (GenAI) tools to deploy a malicious campaign aimed at compromising Fortinet’s FortiGate firewall appliances. In an ...

Roth conversions to secure tax-free withdrawals during retirement are gaining popularity as Ge n X gets closer to retirement, but financial advisers warn that the decision to convert should be ...

I wore the world's first HDR10 smart glasses TCL's new E Ink tablet beats the Remarkable and Kindle Anker's new charger is one of the most unique I've ever seen Best laptop cooling pads Best flip ...

Cigna's top brass said that the company has anticipated a "clearing event" in the pharmacy benefit management industry, and that its new model aligns with regulators' push toward greater transparency.

The Trump administration announced that the company, a pharmacy benefit manager, had agreed to make significant changes to its practices. By Rebecca Robbins and Reed Abelson The reporters have ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...